Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinacalcet in Pediatric CKD with Secondary HPT
NCT01439867Phase 2Terminated
- Sponsor
- Amgen
- Start
- Jun 2012
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 2 trial of cinacalcet in secondary hyperparathyroidism (SHPT), sponsored by Amgen. Started Jun 2012; status: terminated.
02
Drugs
cinacalcet
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT01439867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01439867.